Previous 10 | Next 10 |
2023-06-22 13:45:32 ET Shares of clinical-stage biotech Dice Therapeutics (NASDAQ: DICE) jumped by 37.5% during the first three and a half days of trading this week, according to data provided by S&P Global Market Intelligence . The big gain came after the company announced ...
2023-06-21 11:30:00 ET On Tuesday, Eli Lilly (NYSE: LLY) agreed to pay $2.4 billion for the autoimmune disease specialist Dice Therapeutics (NASDAQ: DICE) . Through this deal, Lilly will gain two experimental immunology medicines: the mid-stage psoriasis candidate DC-806 and...
NEW YORK, NY / ACCESSWIRE / June 21, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Chinook Therapeutics, Inc. (NASDAQ:KD...
NEW YORK, NY / ACCESSWIRE / June 20, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Surface Oncology, Inc. (NASDAQ:SURF)'...
2023-06-20 16:01:41 ET You might say that Eli Lilly and Co. (NYSE: LLY) is rolling the dice. The big drugmaker announced on Tuesday that it plans to acquire Dice Therapeutics (NASDAQ: DICE) in an all-cash transaction valued at around $2.4 billion. Here's what investors need ...
2023-06-20 11:28:10 ET Shares of Dice Therapeutics (NASDAQ: DICE) were up more than 37% early Tuesday morning after the healthcare company announced it was being bought out by pharmaceutical company Eli Lilly (NYSE: LLY) . Dice's shares are up more than 48% this year. ...
2023-06-20 11:22:42 ET The biotechnology sector is an exciting and dynamic area within the broader healthcare industry. It primarily involves the application of biological systems, organisms, or derivatives to develop or manufacture novel products or technologies. These include everything f...
2023-06-20 10:15:03 ET Dice Therapeutics Inc ( NASDAQ: DICE ) opened more than 35% up this morning after Eli Lilly & Co ( NYSE: LLY ) said it will buy the immunology company for $2.4 billion. Dice stock up on the all-cash agreement The all-cash agreement values each ...
2023-06-20 10:07:39 ET Gainers: DICE Therapeutics ( DICE ) +38% . iCAD ( ICAD ) +17% . Nuwellis ( NUWE ) +14% . Valneva ( VALN ) +14% . Cano Health ( CANO ) +13% . Losers: Surgalign ( SRGA ) -72% . Gracel...
2023-06-20 09:21:21 ET U.S. stock index futures on Tuesday were pointing to a lower start, as investors returned from a long weekend on account of the Juneteenth holiday. Wall Street's benchmark S&P 500 ( SP500 ) index on Friday posted solid gains of more than 2.5% for the w...
News, Short Squeeze, Breakout and More Instantly...
DICE Therapeutics Inc. Company Name:
DICE Stock Symbol:
NASDAQ Market:
DICE Therapeutics Inc. Website:
BiondVax (NASDAQ: BVXV) , a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently recei...
Lilly Completes Acquisition of DICE Therapeutics PR Newswire INDIANAPOLIS , Aug. 9, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE). The acquisition...
BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, was featured in a recent analyst report reiterating a Buy recommendation and a $70 target price The report discussed Eli Lilly’s announcement of a definitive...